Compare Genuine Parts Company (GPC) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genuine Parts Company vs Zoetis Inc — how do they compare? Genuine Parts Company trades at $127.02 (market cap $17.67B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is the larger of the two by market cap, and Genuine Parts Company pays the higher dividend (3.32%). Which is the better fit depends on your goals — on Pluang, investors hold Genuine Parts Company for 75 Days and Zoetis Inc for 70 Days on average.
| GPC | ZTS | |
|---|---|---|
Market Cap | $17.67B | $30.20B |
Volume | 1,079,458 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $149.26 | $147.53 |
52-Week Low | $92.47 | $69.09 |
Typical Hold Time | 75 Days | 70 Days |
Enterprise Value | $23.76B | $37.76B |
Dividend Yield | 3.32% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GPC trades at $127.02, up 1.28% on the day, with a bullish technical signal and analyst consensus price target of $145.75. Recent quarterly earnings show two beats and one miss, while the company prepares for a planned separation of its automotive and industrial units in Q1 2027. Revenue has grown steadily to $24.3B in 2025, but net income margin is thin at 0.13%.
The outlook is supported by the corporate split catalyst and dividend stability, but risks include compressed profitability and rising debt-to-asset ratios. Wall Street sentiment is mixed, with 43% buy ratings, yet the stock offers value with a P/S of 0.71 and exposure to aging vehicle trends.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Genuine Parts Company
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
